These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 11578128)

  • 21. Mucin 6 and Tn antigen expression in canine mammary tumours: correlation with pathological features.
    Tavares C; de Oliveira JT; Lopes C; Carvalheira J; Matos AJ; Rutteman G; Reis CA; Gärtner F
    J Comp Pathol; 2012 Nov; 147(4):410-8. PubMed ID: 22595635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours.
    Millanta F; Asproni P; Canale A; Citi S; Poli A
    Vet Comp Oncol; 2016 Sep; 14(3):270-80. PubMed ID: 24824420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CD44 in canine mammary tumours.
    Paltian V; Alldinger S; Baumgärtner W; Wohlsein P
    J Comp Pathol; 2009 Nov; 141(4):237-47. PubMed ID: 19592009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
    Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
    Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
    Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
    J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary report on the expression of leptin and leptin receptor (ObR) in normal, hyperplastic and neoplastic canine mammary tissues.
    Ressel L; Finotello R; Innocenti VM; Vannozzi I; Poli A
    Res Vet Sci; 2012 Aug; 93(1):343-9. PubMed ID: 21875727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical detection of P-glycoprotein (clone C494) in canine mammary gland tumours.
    Petterino C; Rossetti E; Bertoncello D; Martini M; Zappulli V; Bargelloni L; Castagnaro M
    J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):174-8. PubMed ID: 16629950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues.
    Donnay I; Rauïs J; Wouters-Ballman P; Devleeschouwer N; Leclercq G; Verstegen JP
    J Reprod Fertil Suppl; 1993; 47():501-12. PubMed ID: 8229969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
    Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
    Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
    Faustino AM; van Garderen E; Schalken JA; Nederbragt H
    J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours.
    Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V
    Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of tenascin in melanocytic tumours of dogs.
    Sevastre B; van Ederen AM; Terlou M; Gruys E; Nederbragt H
    J Comp Pathol; 2007 Jan; 136(1):49-56. PubMed ID: 17258226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
    Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
    Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COX-1 and COX-2 expression in canine cutaneous, oral and ocular melanocytic tumours.
    Pires I; Garcia A; Prada J; Queiroga FL
    J Comp Pathol; 2010; 143(2-3):142-9. PubMed ID: 20207364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical detection of COX-2 in feline and canine actinic keratoses and cutaneous squamous cell carcinoma.
    Bardagí M; Fondevila D; Ferrer L
    J Comp Pathol; 2012 Jan; 146(1):11-7. PubMed ID: 21601872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
    Gama A; Alves A; Schmitt F
    Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression levels of the focal adhesion-associated proteins paxillin and p130CAS in canine and feline mammary tumors.
    Scibelli A; d'Angelo D; Pelagalli A; Tafuri S; Avallone L; Della Morte R; Staiano N
    Vet Res; 2003; 34(2):193-202. PubMed ID: 12657211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphology and immunoreactivity of canine and feline extramedullary plasmacytomas.
    Mikiewicz M; Otrocka-Domagała I; Paździor-Czapula K; Gesek M
    Pol J Vet Sci; 2016; 19(2):345-52. PubMed ID: 27487508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.